- CA$3.90bn
- CA$5.06bn
- CA$2.97bn
Annual income statement for ATS, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,183 | 2,577 | 3,033 | 2,533 | 2,973 |
| Cost of Revenue | |||||
| Gross Profit | 614 | 728 | 863 | 655 | 859 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,996 | 2,355 | 2,717 | 2,524 | 2,774 |
| Operating Profit | 187 | 222 | 315 | 9.26 | 199 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 154 | 160 | 247 | -82.9 | 99.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 121 | 128 | 194 | -28 | 71.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 122 | 127 | 194 | -28 | 71.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 122 | 127 | 194 | -28 | 71.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.52 | 1.65 | 2.13 | 1.12 | 0.94 |